Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in PROK — Prokidney Corp.

CIK 1214717 BOSTON, MA
Back to PROK Full portfolio

Position in PROK

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,875,899
+$2,673,468 QoQ
Shares Held
2,390,147
+94.3% QoQ
Ownership
0.791%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 70 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PROK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. PROK ranks #247 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in PROK

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,875,899 2,390,147
2026-03-31 $2,202,431 1,230,409
2025-12-31 $2,682,466 1,197,530
2025-09-30 $2,654,211 1,096,782